TY - JOUR
T1 - Integrated functional genomic analysis enables annotation of kidney genome-wide association study loci
AU - Sieber, Karsten B.
AU - Batorsky, Anna
AU - Siebenthall, Kyle
AU - Hudkins, Kelly L.
AU - Vierstra, Jeff D.
AU - Sullivan, Shawn
AU - Sur, Aakash
AU - McNulty, Michelle
AU - Sandstrom, Richard
AU - Reynolds, Alex
AU - Bates, Daniel
AU - Diegel, Morgan
AU - Dunn, Douglass
AU - Nelson, Jemma
AU - Buckley, Michael
AU - Kaul, Rajinder
AU - Sampson, Matthew G.
AU - Himmelfarb, Jonathan
AU - Alpers, Charles E.
AU - Waterworth, Dawn
AU - Akilesh, Shreeram
N1 - Publisher Copyright:
© 2019 American Society of Nephrology. All Rights Reserved.
PY - 2019/3
Y1 - 2019/3
N2 - Background Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements, such as promoters and enhancers. Although researchers have previously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available. Methods We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podocytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli. Results We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels. We found that genetic variants associated with kidney diseases (GWAS) and kidney expression quantitative trait loci were enriched in regulatory DNA regions. By combiningGWAS, epigenomic, and chromatin conformation data, we functionally annotated 46 kidney disease genes. Conclusions We demonstrate a powerful approach to functionally connect kidney disease-/trait-associated loci to their target genes by leveraging unique regulatory DNA maps and integrated epigenomic and genetic analysis. This process can be applied to other kidney cell types and will enhance our understanding of genome regulation and its effects on gene expression in kidney disease.
AB - Background Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements, such as promoters and enhancers. Although researchers have previously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available. Methods We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podocytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli. Results We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels. We found that genetic variants associated with kidney diseases (GWAS) and kidney expression quantitative trait loci were enriched in regulatory DNA regions. By combiningGWAS, epigenomic, and chromatin conformation data, we functionally annotated 46 kidney disease genes. Conclusions We demonstrate a powerful approach to functionally connect kidney disease-/trait-associated loci to their target genes by leveraging unique regulatory DNA maps and integrated epigenomic and genetic analysis. This process can be applied to other kidney cell types and will enhance our understanding of genome regulation and its effects on gene expression in kidney disease.
UR - https://www.scopus.com/pages/publications/85062220531
U2 - 10.1681/ASN.2018030309
DO - 10.1681/ASN.2018030309
M3 - Article
C2 - 30760496
AN - SCOPUS:85062220531
SN - 1046-6673
VL - 30
SP - 421
EP - 441
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 3
ER -